January 2024: Hydrogel-Free Flexcon® Omni-Wave™ for Biosensing

Dry electrode technology saves time and money for manufacturers while improving patient comfort!

Flexcon® Omni-Wave™ hydrogel-free signal receptive media components

Flexcon Global is a leader in coated and laminated films and adhesives used as functional components in manufactured goods and graphics applications. As a material science company, Flexcon serves as a technology partner to innovators around the world.

Flexcon has commercialized Flexcon® Omni-Wave Signal Receptive Media Components, a revolutionary biosensing technology that eliminates the need for hydrogel in medical diagnostic and therapeutic wearable devices.

Omni-Wave technology uses a skin-friendly, medical grade conductive adhesive that requires no hydrogel or Ag/AgCl to get a signal. Omni-Wave is suitable for diagnostic applications such as EKG and sEMG and can distinguish between sympathetic and parasympathetic responses for EDA applications. It is also appropriate for therapeutic applications such as TENS and NMES if a secondary repositionable adhesive is used as a part of the electrode design.

Awarded multiple patents as well as the 2023Med-Tech Award for Materials Innovation, this non-hydrogel “dry” technology combines capacitive and resistive materials to achieve optimal biosignal sensing. Independent clinical studies have shown that the performance of
Omni-Wave components is equivalent to hydrogel-based diagnostic and therapeutic devices. Furthermore, performance is not affected by humidity, allowing patients to shower, bathe, and exercise normally. Omni-Wavetechnology passes ISO 10993-10 for sensitization and irritation and is AAMI compliant. It is an approved component in customer 510(k) and CE marked finished good medical devices.

No hydrogel means a reduced chance of skin irritation for patients who are sensitive to hydrogel. In addition, Omni-Wave offers a cost-savings for medical device manufacturers and converter/fabricators. Savings are realized via fewer changeovers, no special handling, no requirement for expensive barrier packaging, and longer out-of-pack life.

Save processing time and money with Flexcon®Omni-Wave™

“This is a disruptive technology that will enable medical device manufacturers to differentiate their product offering without sacrificing performance while providing an improved experience for patients with hydrogel allergies,” says Kelly Johnson, Product Manager - Healthcare, Flexcon. “Processing efficiencies, elimination of expensive barrier packaging as well as a 4X longer material shelf life are added bonuses.”

Omni-Wave is in stock and ready to be licensed to OEMs for incorporation to finished devices.

Visit our website for more information, to request samples, or to connect with a specialist.

Sam Draper
January 1, 2024

January 2024

Innovation of the Month

Do you want to discover more, visit the website
Visit Website

Other news

World’s First Immersive Gastronomy Experience

Combination of multisensory experience with VR and delicious food for a mixed-reality meal.

Spectralink S Series with Enhanced User Experience

Spectralink has launched Spectralink S Series – a new family of enterprise-grade wireless handsets.

Peloton Expands Portfolio, Buys Wearables, AI, Hardware Startups

Peloton has bought startups Aiqudo, Atlas Wearables and Otari in recent months. Respectively...

Rockley Photonics Unveils Full-Stack Spectrophotometer-Based Sensor Solution for Health Monitoring

Rockley Photonics, a leading global silicon photonics technology company, today revealed its ...
Discover more